
STAAR Surgical Company STAA
$ 20.96
3.71%
Annual report 2026
added 03-03-2026
STAAR Surgical Company ROCE Ratio 2011-2026 | STAA
Annual ROCE Ratio STAAR Surgical Company
| 2026 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -26.65 | -3.17 | 7.28 | 13.03 | 12.75 | 6.88 | - | 4.72 | -7.43 | -11.84 | -18.87 | 1.61 | - | -3.25 | 8.0 |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 13.03 | -26.65 | -1.3 |
Quarterly ROCE Ratio STAAR Surgical Company
| 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q4 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -18.75 | -22.65 | -10.84 | 3.65 | 5.32 | 5.65 | 5.15 | 4.88 | 9.12 | 11.7 | 14.99 | 14.31 | 17.46 | 16.36 | 15.21 | 11.17 | 13.79 | 13.26 | 8.12 | 1.33 | 3.56 | 3.17 | 6.97 | 6.57 | 7.76 | 6.72 | 5.82 | 4.08 | 6.52 | 7.75 | 2.39 | -5.5 | -10.02 | -16.98 | -19.55 | -36.7 | -41.81 | -42.4 | -41.13 | -13.65 | -17.47 | -16.18 | -15.12 | -10.4 | -9.94 | -5.66 | -0.34 | 5.78 | 5.49 | 4.75 | 2.23 | 0.07 | 2.57 | 5.36 | 9.85 | 7.18 | 2.5 | 3.97 | 0.71 |
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 17.46 | -42.4 | -1.22 |
ROCE Ratio of other stocks in the Medical instruments industry
| Issuer | ROCE Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Cooper Companies
COO
|
8.29 | $ 70.29 | 0.17 % | $ 14 B | ||
|
Atrion Corporation
ATRI
|
9.3 | - | - | $ 810 M | ||
|
Luminex Corporation
LMNX
|
5.75 | - | - | $ 1.75 B | ||
|
Akers Biosciences, Inc.
AKER
|
-131.33 | - | -9.52 % | $ 20.6 M | ||
|
Alcon
ALC
|
-2.56 | $ 74.63 | 0.09 % | $ 40.4 B | ||
|
Antares Pharma, Inc.
ATRS
|
9.12 | - | - | $ 955 M | ||
|
Cantel Medical Corp.
CMD
|
2.55 | - | -1.18 % | $ 3.4 B | ||
|
CRH Medical Corporation
CRHM
|
-3.75 | - | - | $ 282 M | ||
|
Hill-Rom Holdings, Inc.
HRC
|
11.0 | - | -0.05 % | $ 10.3 B | ||
|
Baxter International
BAX
|
-5.03 | $ 16.65 | -0.18 % | $ 8.54 B | ||
|
Varian Medical Systems, Inc.
VAR
|
17.41 | - | -0.02 % | $ 16.3 B | ||
|
BioLife Solutions
BLFS
|
-2.04 | $ 19.27 | -1.23 % | $ 888 M | ||
|
AtriCure
ATRC
|
-1.92 | $ 29.19 | 0.41 % | $ 1.39 B | ||
|
electroCore
ECOR
|
769.63 | $ 7.04 | 3.53 % | $ 59.7 K | ||
|
Ekso Bionics Holdings
EKSO
|
-147.62 | $ 9.75 | 3.72 % | $ 23.7 M | ||
|
Glaukos Corporation
GKOS
|
-27.87 | $ 116.69 | 3.48 % | $ 5.65 B | ||
|
Haemonetics Corporation
HAE
|
27.02 | $ 58.46 | 2.87 % | $ 2.94 B | ||
|
Harvard Bioscience
HBIO
|
-353.72 | $ 5.53 | 6.35 % | $ 245 M | ||
|
ICU Medical
ICUI
|
2.02 | $ 122.99 | -0.26 % | $ 3.03 B | ||
|
InfuSystem Holdings
INFU
|
3.45 | $ 9.43 | 1.51 % | $ 195 M | ||
|
iRhythm Technologies
IRTC
|
-37.58 | $ 117.22 | 0.36 % | $ 3.75 B | ||
|
Isoray
ISR
|
-54.85 | - | 0.03 % | $ 108 M | ||
|
Intuitive Surgical
ISRG
|
16.53 | $ 452.58 | 0.11 % | $ 162 B | ||
|
Repro Med Systems
KRMD
|
-17.44 | $ 4.26 | -1.39 % | $ 197 M | ||
|
LeMaitre Vascular
LMAT
|
17.26 | $ 109.16 | 0.62 % | $ 2.47 B | ||
|
Masimo Corporation
MASI
|
-25.35 | $ 178.49 | -0.06 % | $ 9.51 B | ||
|
Microbot Medical
MBOT
|
-19.01 | $ 2.36 | -1.67 % | $ 108 M | ||
|
Milestone Scientific
MLSS
|
-202.54 | $ 0.29 | 1.9 % | $ 23.8 M | ||
|
Merit Medical Systems
MMSI
|
11.66 | $ 67.81 | 0.16 % | $ 4.01 B | ||
|
Envista Holdings Corporation
NVST
|
6.96 | $ 25.81 | - | $ 4.34 B | ||
|
Predictive Oncology
POAI
|
-379.14 | - | - | $ 31.1 M | ||
|
Pro-Dex
PDEX
|
22.96 | $ 48.53 | -6.08 % | $ 160 M | ||
|
Pulse Biosciences
PLSE
|
-95.39 | $ 22.94 | -0.26 % | $ 1.55 B | ||
|
ResMed
RMD
|
22.7 | $ 224.93 | 0.37 % | $ 32.9 B | ||
|
Retractable Technologies
RVP
|
-28.47 | $ 0.71 | 2.98 % | $ 21.3 M | ||
|
NeuroMetrix
NURO
|
-61.36 | - | 5.05 % | $ 9.02 M | ||
|
STERIS plc
STE
|
13.12 | $ 219.97 | 0.58 % | $ 21.7 B | ||
|
Stereotaxis
STXS
|
-164.02 | $ 1.88 | -0.53 % | $ 171 M | ||
|
Teleflex Incorporated
TFX
|
0.44 | $ 115.04 | -2.35 % | $ 5.13 B | ||
|
Utah Medical Products
UTMD
|
9.56 | $ 62.93 | -0.3 % | $ 204 M | ||
|
West Pharmaceutical Services
WST
|
18.42 | $ 256.85 | 0.8 % | $ 18.6 B | ||
|
DENTSPLY SIRONA
XRAY
|
-31.52 | $ 11.64 | 0.09 % | $ 2.32 B | ||
|
AngioDynamics
ANGO
|
-21.84 | $ 9.84 | -4.56 % | $ 402 M | ||
|
Becton, Dickinson and Company
BDX
|
10.16 | $ 155.32 | 0.52 % | $ 44.7 B | ||
|
Nephros
NEPH
|
-19.06 | $ 2.86 | -0.35 % | $ 29.7 M | ||
|
OraSure Technologies
OSUR
|
-19.81 | $ 3.08 | - | $ 226 M | ||
|
Repligen Corporation
RGEN
|
1.79 | $ 116.95 | -0.7 % | $ 6.52 M |